Immunic Presents Clinical and Preclinical Data for IMU-856 at Digestive Disease Week 2023, Including Its Molecular Mode of Action ...Middle East

PR Newswire - News
Immunic Presents Clinical and Preclinical Data for IMU-856 at Digestive Disease Week 2023, Including Its Molecular Mode of Action
– IMU-856 is an Orally Available, Systemically Acting, Highly Selective and Potent Small Molecule Modulator of SIRT6 – – Targets Regeneration of Bowel Epithelium and Restoration of Intestinal Barrier Function – – Builds on Recently Released Phase 1b Data Showing Beneficial Effects in...

Hence then, the article about immunic presents clinical and preclinical data for imu 856 at digestive disease week 2023 including its molecular mode of action was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Immunic Presents Clinical and Preclinical Data for IMU-856 at Digestive Disease Week 2023, Including Its Molecular Mode of Action )

Apple Storegoogle play

Last updated :

Also on site :